Evidence map›Paper›PMID 31690794›Full record

ArticleScientific reports2019

Decreased expression of femXAB genes and fnbp mediated biofilm pathways in OS-MRSA clinical isolates.

Umarani Brahma, Paresh Sharma, Shweta Murthy, Savitri Sharma, Shalini Chakraborty, Sundarapu Naga Appalaraju, Vasundhra Bhandari

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Methicillin-ResistantAntibiotics (Basel, Switzerland) · 2025
    Review
  7. Article
  8. Article
  9. Article
  10. Molecular detection of multidrug and methicillin resistance inOne health (Amsterdam, Netherlands) · 2024
    Article
  11. Article
  12. Natural compounds in the fight againstFrontiers in pharmacology · 2024
    Review
  13. Synergistic Antibacterial Effect of Ethyl Acetate Fraction ofAdvances in pharmacological and pharmaceutical sciences · 2023
    Article
  14. Article
  15. Article
  16. Review
  17. Emergence of a NDM-1-producing ST25Frontiers in microbiology · 2022
    Article
  18. Article
  19. Reduced Growth ofFrontiers in microbiology · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Umarani BrahmaNational Institute of Animal Biotechnology, Hyderabad, India.
Paresh SharmaNational Institute of Animal Biotechnology, Hyderabad, India.
Shweta MurthyNational Institute of Animal Biotechnology, Hyderabad, India.
Savitri SharmaL.V. Prasad Eye Institute, Hyderabad, India.
Shalini ChakrabortyNational Institute of Animal Biotechnology, Hyderabad, India.
Sundarapu Naga AppalarajuNational Institute of Animal Biotechnology, Hyderabad, India.
Vasundhra BhandariNational Institute of Animal Biotechnology, Hyderabad, India. vasundhra23@gmail.com.
National Institute of Animal Biotechnology · INL V Prasad Eye Institute · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Methicillin-Resistant Staphylococcus aureus (MRSA) is a significant threat to human health. Additionally, biofilm forming bacteria becomes more tolerant to antibiotics and act as bacterial reservoir leading to chronic infection. In this study, we characterised the antibiotic susceptibility, biofilm production and sequence types (ST) of 74 randomly selected clinical isolates of S. aureus causing ocular infections. Antibiotic susceptibility revealed 74% of the isolates as resistant against one or two antibiotics, followed by 16% multidrug-resistant isolates (MDR), and 10% sensitive. The isolates were characterized as MRSA (n = 15), Methicillin-sensitive S. aureus (MSSA, n = 48) and oxacillin susceptible mecA positive S. aureus (OS-MRSA, n = 11) based on oxacillin susceptibility, mecA gene PCR and PBP2a agglutination test. All OS-MRSA would have been misclassified as MSSA on the basis of susceptibility test. Therefore, both phenotypic and genotypic tests should be included to prevent strain misrepresentation. In addition, in-depth studies for understanding the emerging OS-MRSA phenotype is required. The role of fem XAB gene family has been earlier reported in OS-MRSA phenotype. Sequence analysis of the fem XAB genes revealed mutations in fem × (K3R, H11N, N18H and I51V) and fem B (L410F) genes. The fem XAB genes were also found down-regulated in OS-MRSA isolates in comparison to MRSA. In OS-MRSA isolates, biofilm formation is regulated by fibronectin binding proteins A & B. Molecular typing of the isolates revealed genetic diversity. All the isolates produced biofilm, however, MRSA isolates with strong biofilm phenotype represent a worrisome situation and may even result in treatment failure.

Indexed as

BiofilmsAnti-Bacterial AgentsBacterial ProteinsDown-RegulationGenotypeHumansMethicillin-Resistant Staphylococcus aureusMicrobial Sensitivity TestsMultilocus Sequence TypingPhenotypeStaphylococcal InfectionsStaphylococcus aureusAnti-Bacterial AgentsBacterial Proteins

Identifiers

PMID31690794
PMCPMC6831631
OpenAlexW2987357824

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.